December 30, 2020December 30, 2020COVID Has Highlighted the Lasting Dangers of Quinoline Drugs; The VA Continues to Award Additional Mefloquine Ratings; and More
April 8, 2020April 8, 2020FDA Approves Chloroquine and Hydroxychloroquine for Emergency Use Against COVID-19; Online Annual Meeting Update; Russian Mefloquine Disinformation?
March 16, 2020March 16, 2020Ask Your Senator To Support Research on Quinism; VA Awards Another 100% Mefloquine Rating; GSK Asks for Krintafel® Label Change; Annual Meeting Update
January 24, 2020January 24, 2020Register Now for our 3rd Annual Meeting, April 27th-28th, 2020; Irish Military Abandons Lariam-or-Nothing Policy; Support The Quinism Foundation
January 7, 2020January 8, 2020The Quinism Foundation Celebrates Its 2nd Anniversary; Mefloquine Report Expected Soon; New Law May Aid U.S. Veterans Harmed by Tafenoquine
November 13, 2019November 13, 2019Top General Joins Canadian Mefloquine Lawsuit; The V.A. Continues to Award New Mefloquine Claims; Participate in the U.S. Mefloquine Study
August 12, 2019August 15, 2019New Mefloquine Study Announced; U.K. Science Media Centre Asked to Correct Inaccurate Information on Mefloquine; Canadian Educational Meeting Update
July 19, 2019July 19, 2019The American Legion Magazine Article on Mefloquine; Support Research and Education on Quinism
May 31, 2019May 31, 2019The Royal Canadian Legion Grants $25,000 to Support Quinism Education and Research; Are You Among the 1%?; Chris Hrudka's Story
April 4, 2019April 4, 2019Less than Four Weeks Until Our Annual Meeting — Agenda Announced; Textbook Chapter on Quinism is Published; Are You Among the 1%?
March 27, 2019March 27, 2019Watch the Second National Academies Meeting Live Today at 9:30 a.m. EDT; Canadian Mefloquine Lawsuit Media Coverage; Recent Foundation Publications
March 16, 2019March 16, 2019Australian $2.1M Mefloquine & Tafenoquine Veterans Program; Canadian Lawsuit Virtual Town Hall; NASEM Meeting; Six Weeks Until the 2019 Annual Meeting
February 25, 2019February 27, 2019Only Two Months Until the 2019 Annual Meeting — Make Plans Now to Join Us in White River Junction, Vermont; Canadian Mefloquine Veterans Plan Lawsuits
February 5, 2019February 5, 2019The 2019 Annual Meeting is Less Than 3 Months Away — Register Now; The VA Disappoints Veterans with the National Academies Study
January 7, 2019January 7, 2019National Academies to Study Mefloquine; VA Rejects Call to Screen Veterans for Mefloquine Exposure; 2019 Annual Meeting
January 2, 2019January 2, 20192018 in Review; Become a Media Ambassador; Make Plans Now to Attend our 2019 Annual Meeting in Vermont
December 20, 2018December 20, 2018Canadian Firms Plan Mefloquine Legal Action for Veterans; Talking to Your Physician About Mefloquine Poisoning; Plan to Attend Our 2019 Annual Meeting
December 13, 2018December 13, 2018Roche Sued in California Court for Lariam; Annual Meeting Update; Peace Corps Told to Investigate Mefloquine
November 29, 2018November 29, 2018VA Misattributing Mefloquine Effects to PTSD; Screening Veterans For Mefloquine Exposure; Mefloquine and the Peace Corps; 2019 Annual Meeting
November 14, 2018November 14, 2018Roche Abandons Lariam; Mefloquine and the Peace Corps; Visit our New Website; Fundraising Update
October 8, 2018October 11, 2018“Adding Mefloquine to An Alzheimer’s Drug is Like Adding Gasoline to a Fire Extinguisher”; Support the Foundation at the 2018 AMSUS Annual Meeting
September 27, 2018September 27, 2018Partnership with Spartan Wellness; 2018 Annual Canadian Educational Meeting Recap
September 17, 2018September 17, 2018Partnership with Lifemark Health Group; Balance Awareness Week; 2018 Annual Canadian Educational Meeting
August 30, 2018August 30, 2018CDC Encouraged to Recommend Against Military Use of Tafenoquine; 2018 Annual Canadian Educational Meeting Update
August 10, 2018August 10, 2018Register Now for the 2018 Annual Canadian Educational Meeting; Tafenoquine Safety Warnings
July 31, 2018July 31, 2018U.K. National Centre for Trauma Partners with The Quinism Foundation to Screen Veterans for Symptomatic Mefloquine Exposure